Approved for use in line with licensed indications and specifically in solid organ transplant and bone marrow transplant recipients.
Itraconazole Infusion
Formulary
250mg in 25ml injection for IV infusion
Posaconazole Noxafil®
Formulary
Approved for the prevention of invasive fungal infection in immunocompromised patients in whom there is a specific risk of aspergillus infection or where fluconazole and itraconazole are not tolerated or are unlikely to be sufficiently effective (largely for secondary prevention).
Approved for patients with invasive fungal infections that are not responding to other treatments or where they are not tolerated (largely in place of liposomal amphotericin/ voriconazole).
Voriconazole
Formulary
for the treatment of non-invasive fungal infections (Off-label indication) using the 100mg tablets ONLY. Can be initiated in primary care on the basis of C&S results / microbiology advice in patients who are not under secondary care.